CTRI/2016/05/006973招募中2 期
Further study on ayurvedic management of oral submucous fibrosis(osmf) - amosmf
INSTITUTE FOR POST GRADUATION TEACHING AND RESEARCH IN AYURVEDA0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •The patients having clinical signs and symptoms of OSMF-blanching and stiffness of oral mucosa, trismus, burning sensation in mouth, intolerance to eating hot and spicy foods, repeated vesicular eruption and ulceration on the bucal mucosa, palate, and pillars; reduced mobility of soft palate and tongue, loss of gustatory sensation etc.
- •Interincisal distance between 15mm-40mm.
排除标准
- •Extensive fibrosis of all the oral mucosa, severe trismus with an interincisal distance of less than 15mm.
- •Disease is most advanced with premalignant and malignant changes.
- •Generalized fibromatosis.
- •Oral manifestation of scleroderma.
- •Oral lichen planus.
- •Pale oral mucosa of anemia.
- •Chronic debilitating conditions like DM, HT, HIV etc.
- •Patients not willing to give up habits of gutkha, pan-masala, mawa, tobacco, betel quid or betel nut chewing.
研究者
相似试验
尚未招募
3 期
Oral submucous fibrosis management through ayurvedaCTRI/2017/12/010863Institute For Post Graduate Teaching And Research In Ayurveda Gujarat Aurved University Jamnagar
已完成
3 期
A clinical trial to study the effects of herbal(ayurvedic) drugs and compare it with commonly used chlorhexidine in patients with chronic periodontitisCTRI/2016/04/006895WHO India408
尚未招募
不适用
Comparison of the efficacy of various treatment modalities in the management of mouth opening, burning sensation in oral submucous fibrosisCTRI/2022/12/048322Dr M Mary Sujatha
已完成
2 期
Tablet PINAK given as treatment to COVID positive patients.CTRI/2020/05/025326Shree Bharadi Ayurvedic106
招募中
2 期
Ayurvedic management of decreased mouth opening due to tobacco chewing.CTRI/2016/06/006987IPGT AND RA30